Strumento inattivo

Altre lingue Peak Pharmaceuticals, Inc. Other OTC

Azioni

CTCO

US70469W1062

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Retrieve Medical Announces Newly Issued Patent for Enhanced Problem List Management in EHR Systems	06/06
Retrieve Medical Holdings, Inc. Announces Newly Issued Patent for Enhanced Problem List Management in EHR Systems	06/06
Retrieve Medical, Inc. Selected to Exhibit Retrieve Dx(TM) at Vizient Innovative Technology Exchange	04/06
Retrieve Medical Announces Significant Results from Physician Burnout Study	02/05
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation	19/04
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation	19/04
Retrieve Medical Holdings, Inc. (RMHI) Announces Study Update Results Utilizing Retrieve Dx ™ Software	22/03
Retrieve Medical Holdings, Inc. Announces Study Update Results Utilizing Retrieve Dx ? Software	22/03
Retrieve Medical Holdings Inc announced that it expects to receive $3 million in funding	14/03
Retrieve Medical Holdings, Inc. Forges Partnership with Louisiana Health System Hospitals	26/02
Retrieve Medical, Inc. Forges Partnership with Louisiana Health System Hospitals	26/02
Retrieve Medical Holdings, Inc. Announces Patent for Enhancing Electronic Health Records	07/02
Retrieve Medical. Inc. Announces Signed Letter of Intent with Louisiana Health System Hospitals, to Immediately Begin the Implementation Phase of Their Patented Software Solution, Retrieve DX	18/12
Retrieve Medical Holdings, Inc. Announces Study Results Utilizing Retrieve Dx Software	24/10/23
Peak Pharmaceuticals, Inc. announced that it has received $0.3185 million in funding	14/08/23
Retrieve Medical. Inc. Announces New Contract with Healthcare Enterprise Technology Company	21/06/23
Retrieve Medical, Inc. Announce Signed Contract with Regional Medical Center	31/05/23
Peak Pharmaceuticals, Inc. announced that it expects to receive $0.3185 million in funding	24/04/23
Neil Reithinger Resigns as Sole Director of Peak Pharmaceuticals, Inc	28/03/23
Neil Reithinger Resigns as Chief Financial Officer of Peak Pharmaceuticals, Inc	28/03/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Peak Pharmaceuticals, Inc. Other OTC

Azioni

CTCO

US70469W1062

Altre lingue

Filtri